Table 1 Clinical features, pathology of the kidney and lymph nodes and treatments administered of 26 patients with KD-associated nephrotic syndrome
From: Nephrotic syndrome associated with Kimura’s disease: a case report and literature review
Reported by | Case | Country | Gender | Age | Urine protein (g/24 h) | Serum albumin (g/L) | Serum creatinine(umol/L) | Serum IgE (IU/ml) | Eosinophils (%) | Renal biopsy | Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
X W Xiao | 1 | China | Male | 23 | 12.77 | 34.6 | 88 | 582 | 0.44 | Mesangial proliferation | Steroid+TW |
X F Zhang | 2 | China | Male | 46 | 6 | 26.3 | 62.9 | 43.4 | 0.15 | Minimal change disease | Steroid |
P C Li | 3 | China | Male | 49 | 10.07 | 15.7 | 75 | 0.27 | Mesangial proliferation | Steroid | |
H Sun | 4 | China | Male | 40 | 8.34 | 30.8 | 480 | 0.15 | Acute tubular necrosis | Steroid | |
Y W Zhang | 5 | China | Male | 23 | 6.05 | 23 | 2500 | IgA nephropathy | Steroid+CTX | ||
L L Shao | 6 | China | Male | 42 | 0.27 | 131 | 1316 | 0.354 | IgA nephropathy | MMF | |
J L Meng | 7 | China | Male | 43 | 6 | 15.5 | 115 | 0.574 | Membranous nephropathy | Steroid | |
R Duan | 8 | China | Male | 19 | 39.9 | 944 | 3000 | 0.154 | FSGS | Steroid | |
9 | China | Femal | 35 | 0.84 | 31.2 | 500 | 0.015 | Mesangial proliferation | Steroid | ||
C B Liu | 10 | China | Male | 19 | 3.65 | 97.1 | 272 | 0.32 | Membranous nephropathy | Steroid | |
11 | China | Male | 21 | 5.32 | 185 | 397 | 0.17 | IgA nephropathy | Steroid+TW | ||
12 | China | Male | 36 | 14.1 | 123.76 | 620 | 0.1 | Membranous nephropathy | Steroid+CTX | ||
13 | China | Male | 25 | 12.8 | 88.4 | 989 | 0.44 | Mesangial proliferation | Steroid+TW | ||
14 | China | Male | 14 | 8.65 | 53.04 | 172 | 0.056 | Mesangial proliferation | Steroid+LEF | ||
15 | China | Male | 44 | 7.28 | 44.2 | 107 | 0.168 | Mesangial proliferation | Steroid+LEF | ||
16 | China | Male | 53 | 6.99 | 176.8 | 160 | 0.122 | Mesangial proliferation | Steroid+CTX | ||
17 | China | Male | 48 | 5.27 | 79.56 | 1378 | 0.26 | Membranous nephropathy | Steroid | ||
Y G Sha | 18 | China | Male | 5 | 3.5 | 20.6 | 30 | 2000 | 0.21 | Mesangial proliferation | Steroid |
Koich | 19 | Japan | Male | 9 | 11.1 | 12 | 238 | 4981 | 0.48 | Minimal change disease | Steroid |
Fatih | 20 | Turkey | Male | 21 | 17.3 | 10 | 256 | 1987 | 0.21 | FSGS | Steroid+CsA |
Deepak | 21 | Vietnam | Male | 14 | 4 | 21 | 123 | 0.11 | Mesangial proliferation | Steroid | |
Chan | 22 | China | Male | 25 | 19.7 | 18 | 85 | 1918 | Mesangial proliferation | Steroid | |
S L Zhu | 23 | China | Male | 23 | 9.3 | 16 | 1510 | 0.485 | FSGS | Steroid | |
Mohamed | 24 | Egypt | Male | 50 | 8.9 | 9 | 212 | 0.2 | Membranous nephropathy | Steroid+MMF | |
K Sud | 25 | India | Femal | 24 | 4.1 | 15 | 160 | Minimal change disease | Steroid | ||
Surendra | 26 | India | Male | 18 | 8.6 | 21 | 62 | 0.03 | Mesangial proliferation | Steroid |